Outcomes of elective cancer surgery in COVID-19 survivors: An observational study.
Priya RanganathanBindiya SalunkeAnjana WajekarAafreen SiddiqueKaizeen DaruwallaShreyas ChawatheyDevayani NiyogiPrakash R NayakJigeeshu DivatiaPublished in: Journal of surgical oncology (2022)
In patients who recover from mild to moderate COVID-19, elective cancer surgery can proceed safely even within 7 weeks. Additional preoperative tests may not be indicated in these patients.
Keyphrases
- coronavirus disease
- papillary thyroid
- minimally invasive
- sars cov
- patients undergoing
- coronary artery bypass
- end stage renal disease
- squamous cell
- ejection fraction
- newly diagnosed
- young adults
- prognostic factors
- peritoneal dialysis
- surgical site infection
- squamous cell carcinoma
- lymph node metastasis
- childhood cancer
- skeletal muscle
- acute coronary syndrome
- patient reported
- atrial fibrillation
- weight loss